Overview
Xiaoxia Chen practices in Shanghai, China. Chen is highly rated in 3 conditions, according to our data. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.
Their clinical research consists of co-authoring 103 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung Cancer
- Lung CancerChen isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Lung AdenocarcinomaChen isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesChen isExperienced. Learn about Lung Metastases.
- NecrosisChen isExperienced. Learn about Necrosis.
- PneumoniaChen isExperienced. Learn about Pneumonia.
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma